0001193125-26-057113
SEC filingHerbalife Nutrition Ltd. reported net sales of $5.04 billion for fiscal year 2025, generating a gross profit of $3.92 billion. Operating income was $481.0 million, with net income attributable to Herbalife reaching $228.3 million. The company maintained strong operating cash flow of $333.3 million, though net cash decreased by $62.8 million due to significant investing and financing activities. Key financial metrics include a gross margin of 77.8% and an operating margin of 9.5%. The balance sheet shows total assets of $2.79 billion, but shareholders' deficit of $509.4 million primarily due to accumulated deficit and comprehensive loss. Long-term debt stands at $1.97 billion, contributing to total liabilities of $3.30 billion.
Herbalife Nutrition Ltd. reported fiscal year 2025 results with net sales of $5.04 billion, cost of sales of $1.11 billion, and gross profit of $3.92 billion. Operating income was $481.0 million after selling expenses of $1.78 billion and general and administrative expenses of $1.66 billion. Net income attributable to Herbalife was $228.3 million, with basic and diluted earnings per share of $2.00. The company generated $333.3 million in operating cash flow but used $108.7 million in investing activities and $295.5 million in financing activities, resulting in a net decrease in cash of $62.8 million.
No segment breakdown or geographic mix data was provided in the available financial data. The company reported net sales of $5.04 billion for the fiscal year ending December 31, 2025. Cost of sales was $1.11 billion, resulting in gross profit of $3.92 billion. Other operating income contributed $4.8 million to the company's results. The document does not contain specific information about revenue drivers, product categories, or geographic performance beyond the aggregate figures.
The company achieved a gross margin of 77.8% based on gross profit of $3.92 billion on net sales of $5.04 billion. Operating margin was 9.5% with operating income of $481.0 million. Selling expenses represented 35.3% of net sales at $1.78 billion, while general and administrative expenses accounted for 32.9% at $1.66 billion. Interest expense of $214.4 million significantly impacted pre-tax income, which was $275.1 million before income taxes of $47.3 million.
Operating activities generated $333.3 million in cash flow, primarily from net income of $227.8 million adjusted for depreciation and amortization of $121.2 million and other non-cash items. Investing activities used $108.7 million for property, plant, and equipment purchases ($80.4 million) and business acquisitions ($25.5 million). Financing activities used $295.5 million, mainly for debt repayments including $746.6 million in principal payments and $262.3 million in senior note repayments. The balance sheet shows total assets of $2.79 billion, with current assets of $1.14 billion including cash and equivalents of $353.1 million. Total liabilities were $3.30 billion, including long-term debt of $1.97 billion, resulting in shareholders' deficit of $509.4 million.
No forward-looking statements, management guidance, strategic priorities, or specific risk factors were provided in the available financial data. The document contains only the financial statements and related notes without management discussion and analysis or outlook sections. Investors should refer to the complete 10-K filing for information on future expectations, strategic initiatives, and risk factors that may affect the company's performance.